Alteration of brain monoamines & EEG wave pattern in rat model of Alzheimer's disease & protection by Moringa oleifera

Indian Journal of Medical Research

Volumn 128, Issue 6, 2008, Pages 744-751

  Ganguly, R ^a   Guha, Debjani ^a  

^a UNIVERSITY OF CALCUTTA   (India)

Author keywords

Alzheimer's disease; Colchicine; EEG; Monoamines; Moringa oleifera

Indexed keywords

ALCOHOL; BRAIN MONOAMINE; COLCHICINE; DOPAMINE; MORINGA OLEIFERA EXTRACT; NORADRENALIN; SEROTONIN;

ALPHA RHYTHM; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA RHYTHM; BRAIN CORTEX; CAUDATE NUCLEUS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; HIPPOCAMPUS; MALE; MAZE TEST; MONOAMINERGIC SYSTEM; NEUROPROTECTION; NONHUMAN; PLANT LEAF; RAT; SPIKE WAVE; SPRAGUE DAWLEY RAT; STEREOTACTIC PROCEDURE;

ALZHEIMER DISEASE; ANIMALS; BIOGENIC MONOAMINES; BRAIN CHEMISTRY; DOPAMINE; ELECTROENCEPHALOGRAPHY; MALE; MAZE LEARNING; MORINGA OLEIFERA; NEUROPROTECTIVE AGENTS; NOREPINEPHRINE; PLANT EXTRACTS; RATS; SEROTONIN;

EID: 61849104057     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Trond M. Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioural tasks. Brain Res Rev 2003; 41: 268-87.
2. Francis PT, Palmer AM, Snape M, Wilcock GK. The cholinergic hypothsis of Alzheimer's disease: a review of progress. J Neurol Neurosurg Psychiatry 1999; 66: 137-47.
3. Faizi S, Siddiqui BS, Saleem R, Siddiqui S, Aftab K, Gilani AH. Fully acetylated carbamates and hypotensive thiocarbamate glycosides from Moringa oleifera. Phytochemistry 1995; 38: 957-63.
4. Caceres A, Saravia A, Rizzo S, Zabala L, Leon ED, Nave F. Pharmacological properties of Moringa oleifera. 2: screening for antispasmodic, anti-inflammatoryand diuretic activity. J Ethnopharmacol 1992; 36: 233-7.
5. Majumdar K, Gupta M, Chakrobarty S, Pal DK. Evaluation of hematological and hepatorenal functions of methanolic extract of Moringa oleifera Lam. root treated mice. Indian J Exp Biol 1999; 37: 612-4.
6. Mohan M, Kaul N, Punekar A, Girnar R, Junnare P, Patil L. Nootropic activity of Moringa oleifera leaves. J Nat Remedies 2005; 5: 59-62.
7. Ganguly R, Hazra R, Ray K, Guha D. Effect of Moringa oleifera in experimental model of Alzheimer's disease: Role of antioxidants. Ann Neurosci 2005; 12: 36-9.
8. Ganguly R, Guha D. Protective role of an Indian herb, Moringa oleifera in memory impairment by high altitude hypoxic exposure: Possible role of monoamines. Biogenic Amines 2006; 20: 121-33.
9. Hazra R, Guha D. Effect of chronic administration of Acorus calamus on electrical activity and regional monoamine levels in rat brain. Biogenic Amines 2003; 17: 161-9.
10. Pellegrino LJ, Cushman AJ. A stereotaxic atlas of the rat brain. New York: Appleton Century Crafts; 1967. p. 60.
11. Dwaine FE, Thomas JW. Cholinergic cell loss and cognitive impairment following intraventricular or intradentate injection of colchicine. Brain Res 1990; 517: 157-67.
12. Jonathan AO, Etan JM. Age-related deficits on the radial maze and in fear conditioning: Hippocampal processing and consolidation. Hippocampus 1998; 8: 402-15.
13. Amar A, Mondal S, Sanyal AK. Estimation of brain monoamines. Acta Endocrinol 1982; 101: 180-6.
14. Dringenberg HC, Laporte PP, Diavolitsis P. Increased effectiveness of tacrine by deprenyl co-treatment in rats: EEG and behavioural evidence. Neuroreport 2000; 11: 3513-6.
15. Ganong WF. Neural basis of instinctual behaviour and emotions. In: Dolan J, Langan C, editors. Review of medical physiology. USA: Prentice-Hall International Inc; 1991. p. 239-42.
16. Hermann N, Lanctot KL. From transmitters to treatment: the pharmacotherapy of behavioural disturbances in dementia. Can J Psychiatry 1997; 42 (Suppl 1): 51S-64S.
17. Cummings JL, Coffee CE. Neurobiological basis of behavior. In: Coffee CE, Cummings JL, editors. Textbook of geriatric neuropsychiatry. USA: American Psychiatric Press; 1994. p. 72-96.
18. Eagle DM, Humby T, Dunnet SB, Robbins TW. Effect of regional srtriatal lesions on motor, motivational and executive aspects of progressive ratio performance in rats. Behav Neurosci 1999; 113: 718-31.
19. Daberkow DP, Kesner RP, Keefe KA. Relation between methamphetamine-induced monoamine depletions in the striatum and sequential motor learning. Pharmacol Biochem Behav 2005; 81: 198-204.
20. Joyce JN, Murray AM, Hurtig HI, Gottlieb GL, Trojanowski JQ. Loss of dopamine D2 receptors in Alzheimer's disease with Parkinsonism but not Parkinson's or Alzheimer's disease. Neuropsychopharmacology 1998; 19: 472-80.
21. Stahl SM. Neurotransmission of cognition, part3. Mechanism of action of selective NRIs: both dopamine and norepinephrine increase in pre frontal cortex. J Clin Psychiatry 2003; 64: 230-1.
22. Page IH, Carlson A. Serotonin. In: Lajhya A, editor. Handbook of neurochemistry, vol. IV. New York: Plenum Press; 1970. p. 251.
23. Ha TM, Cho DM, Park SW, Joo MJ, Lee BJ, Kong BG, et al. Evaluating associations between 5-HTTLPR polymorphism and Alzheimer's disease for Korean patients. Dement Geriatr Cogn Disord 2005; 20: 31-4.
24. Hashimoto S, Inoue T, Koyama T. Protective effect of WEB 1881 FU on AF64A (ethylcholine aziridinium ion)-induced impairment of hippocampal cholinergic neurons and learning acquisition. Eur J Pharmacol 1991; 209: 9-14.
25. Brown TH, Chapman PF, Kairiss EW, Keenan CL. Long term synaptic potentiation. Science 1988; 242: 724-8.
26. Bekkers JM, Stevens CF. NMDA and non-NMDA receptors are co-localized at individual excitatory synapses in cultured rat hippocampus. Nature 1989; 341: 230-3.
27. Guyton AC, Hall JE. The cerebral cortex; Intellectual functions of the brain and learning and memory. Harcourt Asia Pvt. Ltd. India; 2006. p. 653.